Insider Deck research · Earnings

URGN earnings · UroGen Pharma Ltd.

UroGen Pharma Ltd. (URGN) earnings history, EPS vs consensus, beat rate, forward estimates, and transcripts on Insider Deck. Latest print Q1 '26: EPS $-0.47 vs consensus $-0.48. Beat rate 25% across 4 prints. Next listed date 2026-08-05.

Latest EPS-$0.47+0.0% surprise

Beat rate25%1 print streak

Avg surprise-0.1%vs consensus

Next printAug 5, 2026EPS -$0.27

Quarterly EPS vs consensus

4 quarters

Actual ConsensusLabels: beat $ · YoY %Revisions 20 up / 0 down

Earnings transcripts

Read management commentary and analyst Q&A.

No transcript dates are available yet for this ticker.

Forward estimates

Consensus expectations and estimate momentum.

PeriodEPSRevenueGrowth

0QJun 2026

-$0.27$63.5M+74.8%

+1QSep 2026

-$0.05$75.6M+92.9%

0YDec 2026

-$0.71$276.5M+77.9%

+1YDec 2027

$1.49$435.3M+311.9%

Primary research

Recent company filings

Jump directly to earnings releases, quarterly reports, and material updates.

Frequently asked questions

When is the next URGN earnings date?

The next listed earnings date for URGN is 2026-08-05. Dates can move — confirm on the earnings desk.

What is URGN's earnings beat rate?

URGN has beaten consensus on roughly 25% of recent prints in the Insider Deck sample.

Where are URGN earnings call transcripts?

Ready transcripts appear under URGN earnings as /stocks/us/urgn/earnings/{year}/q{n}.

Where can I research URGN on Insider Deck?

UroGen Pharma Ltd. (URGN) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.